Navigation Links
Fosamax Lawsuits Update: Rottenstein Law Group LLP Comments on Reported $28 Million Merck ‘Jaw Death’ Settlement
Date:12/10/2013

(PRWEB) December 10, 2013

Drugmaker Merck announced on Dec. 9 that it has agreed to pay about $28 million to settle Fosamax lawsuits stemming from claims that the osteoporosis drug caused patients’ jaws to deteriorate, or even “die,” according to Reuters. The Rottenstein Law Group LLP notes that the settlement involves more than 1,140 lawsuits in federal and state courts.

In order for the settlement to succeed, it requires 100 percent participation from the plaintiffs in the lawsuits, according to a Dec. 9 Reuters story.* The deadline to signal intent to file is Jan. 13. (In Re Fosamax Products Liability Litigation; 06-md-01789, U.S. District Court, Southern District of New York.)

“The decision to settle is not one to approach lightly,” said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP. “Plaintiffs in these Fosamax lawsuits need to consult with their qualified counsel to adequately and accurately assess their needs, and to determine if a settlement is the preferred outcome.”

The settlement applies only to those cases involving the deterioration or death of the jaw, according to Reuters. There are more than 4,000 Fosamax lawsuits involving femur fracture claims in state and federal courts, and those claimants are not eligible for a settlement, Reuters said.

The Rottenstein Law Group LLP encourages people to download a free informational brochure to learn more about the drug’s side effects and how to file a lawsuit.

*reuters.com/article/2013/12/09/us-merck-fosamax-idUSBRE9B811S20131209

About THE ROTTENSTEIN LAW GROUP LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

Contact:
The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com
plus.google.com/106070664376281033016

Read the full story at http://www.prweb.com/releases/fosamax-settlement/fosamax-lawsuits/prweb11409526.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. US Drug Watchdog Now Offers To Help Women Who Used TheOsteoporosis Drug Called Fosamax And Then Had A Unexplainable Femur Fracture Get To The Best Attorneys Or Law Firms
2. US Drug Watchdog Now Offers to Help All Woman Who Used Fosamax For Osteoporosis and Then Had an Unexplained a Femur Break Get to the Best Attorneys
3. The Law Firm of d'Oliveira & Associates Now Offers a No Win - No Fee Promise in Fosamax Cases
4. New Lawsuit Alleges Fosamax Increases Risk of Injury: Now, AttorneyOne Can Provide Advice
5. Fosamax Lawsuit Update: Bernstein Liebhard LLP Notes Nearly 2,600 Claims Alleging Fosamax Femur Fractures, Other Side Effects, Pending in New Jersey State Litigation
6. Fosamax Lawsuits Update: Rottenstein Law Group Responds to Femur Fracture Verdict in Merck’s Favor
7. Fosamax Lawsuits Update: Rottenstein Law Group LLP Responds to Fosamax Cystic Fibrosis Study
8. Warning Labels Update Survives Dismissal in Fosamax Multidistrict Litigation: Now, AttorneyOne Can Provide Advice
9. More than 2,900 Fosamax Lawsuit Claims Now Pending in Multicounty New Jersey Litigation, Proceeding Continues to Move Forward, Bernstein Liebhard LLP Reports
10. LawyersandSettlements.com Issues Report on Prostate Health Claim Lawsuits and Propecia Side Effect Litigation
11. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... ... Will Never Be The Same” is a fictional tale about growing up with the ... the creation of published author, Kim T. Briggs, a self-described “big kid” who has ... and philosophy from Judson University in Elgin, Illinois. Having written numerous Christian drama skits ...
(Date:12/5/2016)... (PRWEB) , ... December 05, 2016 , ... ... ability of physical therapist assistants, under direct supervision of a licensed physical therapist, ... physical therapy receives a consultation and treatment plan from a licensed physical therapist ...
(Date:12/5/2016)... IL (PRWEB) , ... December 05, 2016 , ... The ... to the individual looking to buy neoprene knee sleeves for lifting and ... The design focuses heavily on two main aspects to provide a higher quality knee ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... an excellent way to ensure moisture measurements are consistently correct. However, regular ... , Now, METTLER TOLEDO offers a solution: SmartCal™ . This ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... they have teamed up with The American College of Surgeons (ACS) to provide ... on Trauma, the “Bleeding Control Basic” course is a pilot program that fulfills ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... PARSIPPANY, N.J. , Dec. 5, 2016 ... today announced preliminary safety and efficacy data from ... oral selective MDM2 inhibitor, suggesting that DS-3032 may ... relapsed/refractory acute myeloid leukemia (AML) and high-risk myelodysplastic ... part of the phase 1 study of DS-3032 were ...
(Date:12/5/2016)... , Dec. 5, 2016 Eisai Inc. announced ... the 2016 Annual Meeting of the American Epilepsy Society ... is indicated as an adjunctive therapy for the treatment ... generalized seizures and primary generalized tonic-clonic seizures (PGTC) in ... and older. Please see Important Safety Information for FYCOMPA, ...
(Date:12/5/2016)... BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... candidates, presents positive Phase 2a correlative data, as well as ... at the ongoing 58th American Society of Hematology (ASH) Annual ... . ... As previously announced, in ...
Breaking Medicine Technology: